title: Is There Any Reliable Clinical Evidence to Suggest That Acthar Is More Effective Than Other Forms of Corticosteroids in Treating Sarcoidosis and Other Diseases It Is Being Marketed to Treat?
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of Connecticut School of Medicine, Farmington, CT. Electronic address: metersky@uchc.edu.
authors.forename: Mark L
authors.initials: ML
authors.lastname: Metersky
mesh_terms: D000305:Adrenal Cortex Hormones / Q000191:economics / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000191:economics / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D017277:Drug Approval; D016527:Drug Costs; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D040541:Marketing; D012507:Sarcoidosis / Q000188:drug therapy*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000305:Adrenal Cortex Hormones; D003692:Delayed-Action Preparations; D006728:Hormones; D000324:Adrenocorticotropic Hormone